TCRT icon

Alaunos Therapeutics

124 hedge funds and large institutions have $241M invested in Alaunos Therapeutics in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 38 increasing their positions, 28 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

9% less funds holding

Funds holding: 137124 (-13)

57% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 23

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
124
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.96M
Puts
$5.23M
Net Calls
Net Calls Change

Top Buyers

1 +$17.3M
2 +$6.76M
3 +$1.74M
4
State Street
State Street
Massachusetts
+$1.43M
5
Rafferty Asset Management
Rafferty Asset Management
New York
+$806K

Top Sellers

1 -$8.16M
2 -$1.42M
3 -$1.19M
4
UBS Group
UBS Group
Switzerland
-$1.14M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$991K
Name Holding Trade Value Shares
Change
Change in
Stake
51
$283K
52
$280K
53
$278K
54
$248K
55
$245K
56
$240K
57
$232K
58
$222K
59
$214K
60
$208K
61
$204K
62
$177K
63
$175K
64
$173K
65
$170K
66
$165K
67
$157K
68
$144K
69
$139K
70
$133K
71
$129K
72
$124K
73
$123K
74
$116K
75
$114K